The changing face of the drug delivery industry
This article was originally published in Clinica
Drug delivery system manufacturers are generally seeing buoyant demand at present, with the international market amounting to some $44 billion, equivalent to 13% of the global pharmaceutical market. But stability is a different matter, for while demand is increasing, so are the predatory instincts of the industry's majors. The drug delivery industry is facing consolidation and very soon could be dominated by a handful of multitechnology companies.